|
|
|
prIME Oncology invites you to view exciting news released from the American Association for Cancer Research 101st Annual Meeting.
|
 |
|
This expert interview with George Blumenschein, Jr, MD, from the M. D. Anderson Cancer Center in Houston, Texas; Edward S. Kim, MD, from the M. D. Anderson Cancer Center in Houston, Texas; and Thomas Lynch, Jr, MD, from the Yale Cancer Center in New Haven, Connecticut, along with downloadable slides, highlights the following data release regarding groundbreaking work using biomarkers to select therapy for patients with advanced non-small cell lung cancer (NSCLC).
Abstract # LB-1: The BATTLE trial (Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination): Personalizing therapy for lung cancer
View the Expert Interview and Opinion with George Blumenschein, Jr, MD, Edward S. Kim, MD, and Thomas Lynch, Jr, MD, and access the downloadable slides
|
| |
|
Disclaimer: The information on this site is intended for healthcare professionals based outside of the United States. You will be asked to provide your credentials before accessing the Webcast and slides. This site may contain information on products outside the approved indications where you practice. |
 |
|
|
|
|
|
